J
Q1 2026 13F Highlights: 5 Top Funds in 5 Minutes
15 May was the SEC 13F deadline for Q1 2026. Five top managers I think are worth a read. Here's what changed, in plain SG-investor language.
Natera
NTRA----
Natera (NTRA)
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personaliz...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Natera Analyst Rating
View MoreForecast & Rating
Jul 22, 2026Price forecast
$282.867.96%
Forecast & RatingBuy
22analysts
- Strong buy63.64%
- Buy22.73%
- Hold13.64%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · 2 days ago, 02:55 AM
Bernstein Sticks to Their Buy Rating for Natera (NTRA)
- StockTitan · Jul 21 at 09:00 PM
Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study | NTRA Stock News
- benzinga_article · Jul 21 at 01:52 PM
Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring
- PUBT · Jul 17 at 08:05 PM
Natera co-founder, Director Sheena Jonathan disposes of 1,500 common shares worth $410,322.91
- StockTitan · Jul 16 at 09:35 AM
Finalized MolDx LCD Includes Expanded Coverage for Natera’s Prospera™ Portfolio | NTRA Stock News
- MSN · Jul 16 at 08:11 AM
Billionaire Stanley Druckenmiller's top holding isn't Nvidia. Instead, it's this under-the-radar stock that Wall Street loves.
Posts
View MoreBullish vs. Bearish — Last 3 Months
1.0k followers · 0 opinions
▲Bullish50%
50%Bearish▼